Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wozniacka, A
Right arrow Articles by Mccauliffe, D P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wozniacka, A
Right arrow Articles by Mccauliffe, D P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 11, No. 2, 71-81 (2002)
DOI: 10.1191/0961203302lu147rr

Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit

A Wozniacka

Department of Dermatology, Medical University of Lodz, Lodz, Krzemieniecka, Poland

A Carter

Medical School, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

D P Mccauliffe

Department of Medicine, Division of Dermatology, Box 3135, Duke University Medical Center, Durham, NC 27710, USA,dpmccauliffe{at}juno.com

Antimalarials are arguably the best modality currently available for treating patients with cutaneous lupus erythematosus (LE). Although antimalarials have been used for decades in treating cutaneous LE, the precise mechanisms by which they provide therapeutic benefit are not well defined. The putative mechanisms by which antimalarials might provide therapeutic benefit to patients with cutaneous LE include a number of interrelated anti-inflammatory and immunosuppressive effects that include photoprotection, lysosomal stabilization, suppression of antigen presentation, and inhibition of prostaglandin and cytokine synthesis. If we had a more precise understanding of how antimalarials provide therapeutic benefit in cutaneous LE we might gain better insight into the pathogenic mechanisms of LE and ways of developing better therapies for afflicted patients.

Key Words: LE • cutaneous • antimalarials • hydroxychloroquine • chloroquine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
L. SAILLER, B. PUISSANT, P. MELIANI, J. O. CASTEX, S. SAIVIN, D ADOUE, B FOURNIE, P. ARLET, J.-L. MONTASTRUC, M. LAPEYRE-MESTRE, et al.
Blood Concentrations of Hydroxychloroquine and Its Desethyl Derivative Correlate Negatively with the Percentage of CD45RO+ Cells among CD4+ Lymphocytes in Hydroxychloroquine-Treated Lupus Patients
Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Wozniacka, A Lesiak, J Narbutt, J Kobos, S Pavel, and A Sysa-Jedrzejowska
Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus
Lupus, February 1, 2007; 16(2): 89 - 94.
[Abstract] [PDF]


Home page
LupusHome page
A Wozniacka, A Lesiak, J Narbutt, D P McCauliffe, and A Sysa-Jedrzejowska
Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients
Lupus, May 1, 2006; 15(5): 268 - 275.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. E. Falagas and P. I. Vergidis
Narrative Review: Diseases That Masquerade as Infectious Cellulitis
Ann Intern Med, January 4, 2005; 142(1): 47 - 55.
[Abstract] [Full Text] [PDF]